A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Veloce BioPharma LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females aged 18 years or older
Acute paronychia developing during the course of their monotherapy or combination chemotherapy
Involvement of at least one nail with a Paronychia Severity Grading score of 1 or higher
Eastern Cooperative Oncology Group score ≤ 2
Life expectancy of at least 12 months as per the investigator's judgment
Willing to provide written informed consent
Individuals who are willing to not start any new products OTC or prescription treatments for Paronychia and discontinue any treatment the investigator feels may interfere with the evaluation of the test products
Individuals who are already on antibiotics as prescribed by oncologist for any condition except paronychia
Individuals who are willing to avoid using cosmetic products, creams, salves, or ointments to the treatment area(s)
You may not be if
Mentally incompetent or unable or not willing to give written informed consent or meet study requirements
Without a history of a cancer diagnosis
Without history of cancer diagnosis using chemotherapy
Patients with paronychia requiring surgical intervention at baseline
Patients who are already on prescribed treatment for paronychia who are not willing to discontinue this treatment and only use study drug (no washout period required)
Patient Human Immunodeficiency Virus (HIV) infection
Patients with any medical condition, including alcohol or drug abuse or mental incapacity / hypersensitive to the study drug, which in judgment of the investigator will interfere with the patient's participation in the study or evaluation of study results
Have any medical condition that, in the opinion of the investigator, may interfere with the study results or place the subject at undue risk
Clareo Health | A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients
